Современное лечение поверхностного рака мочевого пузыря

Лопаткин, Н.А.; Мартов, А.Г.; Гущин, Б.Л.; Гнатюк, А.П.

dc.contributor.author	Лопаткин, Н.А.
dc.contributor.author	Мартов, А.Г.
dc.contributor.author	Гущин, Б.Л.
dc.contributor.author	Гнатюк, А.П.
dc.date.accessioned	2022-04-21T12:13:03Z
dc.date.available	2022-04-21T12:13:03Z
dc.date.issued	2002
dc.identifier.citation	ЛОПАТКИН, Н.А., МАРТОВ, А.Г., ГУЩИН, Б.Л., ГНАТЮК, А.П. Современное лечение поверхностного рака мочевого пузыря. В: Dializa și Transplant Renal din Republica Moldova: conferința 3-a de Urologie, conferința 2-a de Nefrologie: culegere de lucrări. Chișinău, 2002, сс. 92-94.
dc.identifier.uri	https://repository.usmf.md/handle/20.500.12710/20455
dc.description.abstract	Summary Superficial bladder cancer (stage Ta-T1) is associated with a high recurrence and progression rate with implications for patient's survival and quality of live. A better understanding of the disease natural history may improve the outcome in superficial bladder cancer patients. The information was gathered from MEDLINE, current urology Journals, abstracts from recent urological meetings and personal experience. Initial treatment consists of complete transurethral resection, tumor bed cold cup biopsy with subsequent vaporization, and adjuvant treatment with intravesical instillation of bacillus Calmefte-Guerin (BCG) or interferon a-2b. Fluorescent cystoscopy, second look TUR allow to decrease risk of progression and recurrence. Early diagnosis and accurate pathological assessment are essential for determining the most adequate treatment strategy.	en_US
dc.language.iso	ru	en_US
dc.publisher	Societatea Urologilor din Republica Moldova	en_US
dc.relation.ispartof	Culegere de lucrări Conferința 3-a de Urologie, Conferința 2-a de Nefrologie: Dializa și Transplant Renal din Republica Moldova (30 - 31 octombie 2002)	en_US
dc.title	Современное лечение поверхностного рака мочевого пузыря	en_US
dc.type	Article	en_US